Table 1.
Patient Characteristics.
| RTRT (n = 12) | g-SBRT (n = 8) | |
|---|---|---|
| Sex | ||
| Men | 11 | 8 |
| Women | 1 | 0 |
| Age (years) | ||
| Median (range) | 66 (55-80) | 65 (48-86) |
| ECOG performance status | ||
| 0 | 1 | 3 |
| 1 | 10 | 4 |
| 2 | 1 | 1 |
| Primary tumor site | ||
| Lung (NSCLC) | 7 (6) | 2 (2) |
| Liver | 1 | 4 |
| Kidney | 3 | 1 |
| Prostate | 1 | 0 |
| Bladder | 0 | 1 |
| Lateralitya | ||
| Left | 6 | 3 |
| Right | 7 | 5 |
| Diameter (mm) | ||
| Median (range) | 56 (19-80) | 38 (14-74) |
| Synchronous extra-adrenal lesion | 7 | 7 |
| Symptoms before RT chemotherapy | 1 | 2 |
| Before RT | 7 | 3 |
| After RT | 10 | 5 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; g-SBRT, general stereotactic body radiotherapy; NSCLC, non-small cell lung cancer; RT, radiotherapy; RTRT, real-time tumor-tracking radiotherapy; SD, standard deviation.
aBoth glands were treated in 1 patient.